RE:The question is .....My thoughts are that the investors that bought in the last few weeks (and increased the share price), they were WELL aware of the situation with CRE and the production timeline. Unless these investors are simply day traders (which will result in the share price decreasing shortly, due to the delay in production).
My unterstanding is that it is not day traders but institutional investors (or people with very large pockets). They don't mind buying in now, since when production starts at the middle/end of 2019, this stock will be in the dollars (should be at least $3+ easily).
As for the timeline, yes, it is dissapointing. But if you remember, they had timelines in the past presentation and they ALWAYS missed the dates. Then for the last few presentations they took out the timelines all together. The project was moving at a much slower pace then they anticipated. Then came HELM along. Then came Dr. Haber along. These are serious players. So the new timeline is also serious. I see them actually sticking to it. Too much is involved here. We are talking about a multi-billion dollar company (HELM) and one of the most respected/trusted individual in the lihium market (Dr. Haber). This alone will bring in investment in CRE.
So even if they trade down today (this week), or even if the share price decreases because of this delay...it is short lived. By the middle of Q2 (let's say June/July), they will bring out the first phase of the FS, along with AN UPDATED NPV. That will be over 1 billion (and most likely closer to 2 billion). So have no fear. If they say the project is worth $2 billion, do you really think that it will trade at $130M market cap??? You do the math. GLTA.
One last thing. I see CRE moving to the TSX (instead of staying on the venture exchange), in the near future. I see this happening before production (and maybe even before they secure some financing). That's just my opinion.